r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

GM

George Magrath

Insider · Chief Executive Officer · IRD

George Magrath files insider transactions with the SEC as a chief executive officer of Opus Genetics. We hold 3 disclosed purchases and sales filed since 3 November 2023, 1 of them in the last 90 days.

  • Files for 2 companiesIRD, OCUP
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure11 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 November 2024 — 9 September 2026Chief Executive Officer · Opus Genetics 20 Form 4 lines · source: SEC Form 4
  • Filed 1 November 2023 — 17 May 2024Chief Executive Officer · Ocuphire Pharma 4 Form 4 lines · source: SEC Form 4

Every transaction

24 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
24 of 24 shown
9 Sep 202611 Sep 2026SEC Form 42 dexercised options overnot a tradeOpus Genetics392,157 sharesup +5.4%up +0.0%
9 Sep 202611 Sep 2026SEC Form 42 dhad shares withheld for taxnot a tradeOpus Genetics75,541 sharesup +5.4%up +0.0%
9 Sep 202611 Sep 2026SEC Form 42 dexercised options overnot a tradeOpus Geneticsderivative392,157 sharesup +5.4%up +0.0%
23 Jul 202627 Jul 2026SEC Form 44 dsold on the open marketOpus Genetics9,475 sharesup +106.8%up +80.3%
23 Apr 202627 Apr 2026SEC Form 44 dsold on the open marketOpus Genetics9,511 sharesup +15.9%up +18.0%
16 Mar 202618 Mar 2026SEC Form 42 dsold on the open marketOpus Genetics24,438 sharesup +16.4%up +29.6%
16 Mar 202618 Mar 2026SEC Form 42 dsold on the open marketOpus Genetics24,438 sharesup +16.4%up +29.6%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeOpus Genetics483,639 sharesup +141.6%up +114.9%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeOpus Genetics483,639 sharesup +141.6%up +114.9%
1 Nov 20255 Nov 2025SEC Form 44 dhad shares withheld for taxnot a tradeOpus Genetics30,350 sharesup +162.6%up +184.9%
1 Nov 20254 Nov 2025SEC Form 43 dhad shares withheld for taxnot a tradeOpus Genetics30,350 sharesup +162.6%up +178.3%
24 Mar 202526 Mar 2025SEC Form 42 dwas grantednot a tradeOpus Geneticsderivative392,157 sharesup +425.2%up +486.4%
24 Mar 202526 Mar 2025SEC Form 42 dwas grantednot a tradeOpus Genetics392,157 sharesup +425.2%up +486.4%
13 Mar 202517 Mar 2025SEC Form 44 dwas grantednot a tradeOpus Geneticsderivative330,697 sharesup +549.5%up +542.6%
13 Mar 202517 Mar 2025SEC Form 44 dwas grantednot a tradeOpus Genetics330,697 sharesup +549.5%up +542.6%
26 Dec 202430 Dec 2024SEC Form 44 dbought on the open marketOpus Genetics100,000 sharesup +459.3%up +439.3%
23 Dec 202423 Dec 2024SEC Form 40 dwas grantednot a tradeOpus Genetics6,200 sharesup +486.4%up +486.4%
18 Nov 202419 Nov 2024SEC Form 41 dbought on the open marketOpus Genetics9,706 sharesup +563.7%up +586.4%
15 Nov 202419 Nov 2024SEC Form 44 dbought on the open marketOpus Genetics90,294 sharesup +469.8%up +586.4%
1 Nov 20245 Nov 2024SEC Form 44 dhad shares withheld for taxnot a tradeOpus Genetics37,050 sharesup +411.9%up +416.2%
17 May 202421 May 2024SEC Form 44 dbought on the open marketOcuphire Pharma5,000 sharesup +257.4%up +249.1%
18 Mar 202420 Mar 2024SEC Form 42 dbought on the open marketOcuphire Pharma25,000 sharesup +213.0%up +205.1%
1 Nov 20233 Nov 2023SEC Form 42 dwas grantednot a tradeOcuphire Pharmaderivative600,000 sharesup +110.5%up +120.4%
1 Nov 20233 Nov 2023SEC Form 42 dwas grantednot a tradeOcuphire Pharma400,000 sharesup +110.5%up +120.4%

Both percentages are the stock’s move, not George Magrath’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 24 of the 24 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.